Zhi-qing Qiao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion.
Journal: Science progress
Published: July 18, 2022
Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial).
Journal: Annals of translational medicine
Published: May 02, 2020
Initial anticoagulation experience with standard-dose rivaroxaban after Watchman left atrial appendage occlusion.
Journal: Annals of translational medicine
Published: March 17, 2020
Combined use of external therapeutic ultrasound and tirofiban has synergistic therapeutic effects on no-reflow after myocardial reperfusion.
Journal: Echocardiography (Mount Kisco, N.Y.)
Published: July 06, 2018
Optimal nonvitamin K antagonist oral anticoagulant therapy in a warfarin-sensitive patient after left atrial appendage closure: A case report.
Journal: Medicine
Published: May 03, 2018
Impact of Early ST-Segment Changes on Cardiac Magnetic Resonance-Verified Intramyocardial Haemorrhage and Microvascular Obstruction in ST-Elevation Myocardial Infarction Patients.
Journal: Medicine
Published: September 04, 2015
Early resolution of ST-segment elevation after reperfusion therapy for acute myocardial infarction: Its relation to echocardiography-determined left ventricular global and regional function and deformation.
Journal: Journal of electrocardiology
Published: August 12, 2014
Pharmacoinvasive therapy for ST elevation myocardial infarction in China: a pilot study.
Journal: Journal of thrombosis and thrombolysis
Published: November 19, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026